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New JerseyABSTRACT Cationic amino acid transporters are highly selective for L-enantiomers such as L-arginine (L-Arg). Because of
this stereoselectivity, little is known about the interaction of these transporters with D-isomers. To study whether these
compounds can provide information on the molecular mechanism of transport, inward currents activated by L-Arg with low
apparent affinity were measured in whole-cell voltage-clamped cardiomyocytes as a function of extracellular L-Arg and D-Arg
concentrations. D-Arg inhibited L-Arg currents in a membrane-potential (VM)-dependent competitive manner, indicating the
presence of D-Arg binding sites in the carrier. Analysis of these steady-state currents showed that L- and D-Arg binding reac-
tions dissipate a similar small fraction of the membrane electric field. Since D-Arg is not transported, these results suggest that
enantiomer recognition occurs at conformational transitions that initiate amino acid translocation. The VM dependence of
maximal current levels suggests that inward currents arise from the slow outward movement of negative charges in the unli-
ganded transporter. Translocation of the L-Arg-bound complex, on the other hand, appears to be electroneutral. D-Arg-depen-
dent transient charge movements, also detected in these cells, displayed a VM-dependent charge distribution and kinetics that
are consistent with amino acid binding in an ion well in a shallow, water-filled extracellular binding pocket.INTRODUCTIONCardiac muscle cells depend entirely on transport from the
circulation to ensure adequate intracellular levels of cationic
amino acids. In particular, arginine-activated currents
measured in these cells represent import of this amino
acid through a low-affinity process that is consistent with
the activity of CAT-2A (1), a member of the system-yþ
family of cationic amino acid transporters (2,3). This low-
affinity transport activity accounts for at least 50% of the
total incorporated arginine at normal plasma levels of this
amino acid, the other half being transported by the high-
affinity/low-capacity CAT-1 (4). Among its many roles in
physiology, arginine is the substrate for the biosynthesis of
nitric oxide, a signaling molecule with major regulatory
effects on the cardiovascular system (5,6).
System-yþ carriers, which include the high-affinity
CAT-1, CAT-2B, and CAT-3, as well as the low-affinity
CAT-2A, display high selectivity for the L-enantiomers of
arginine (L-Arg), lysine (L-Lys), and ornithine (L-Orn).
These amino acids are transported in a Naþ-independent
manner down their electrochemical potential gradient and,
within a given isoform, with similar apparent affinities
(reviewed in Deve´s and Boyd (7)). In addition, radiolabeled
cationic L-amino acid uptake mediated by system-yþ trans-
porters is accelerated by the presence of unlabeled substrateSubmitted August 9, 2010, and accepted for publication September 16,
2010.
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0006-3495/10/11/3224/10 $2.00at the other side of the membrane, a signature feature called
trans-stimulation (8) that indicates that the kinetics of
binding-site translocation are faster in the presence of
substrate (reviewed in Deve´s and Boyd (7)). The high-
affinity isoforms display up to 10-fold trans-stimulation,
whereas CAT-2A has been reported to be somewhat irre-
sponsive to stimulation by trans-substrate (2). In contrast,
our recent work has shown that low-affinity L-Lys uptake
is trans-stimulated approximately threefold in cardiac
sarcolemmal vesicles (4). Besides these general characteris-
tics, the molecular mechanisms of amino acid transport by
members of this family remain largely unknown.
The stereoselectivity of these carriers and the biological
significance of L-amino acids have drawn attention away
from D-enantiomers. Nonetheless, it is pertinent to the
transport mechanism to learn whether these proteins bind
D-isomers and, if so, how they distinguish between
compounds that are three-dimensional mirror images. To
the best of our knowledge, only two publications have dealt
with D-Arg effects on members of system yþ, yielding over-
all inconclusive results. In one case, D-Arg was reported to
be a competitive inhibitor of L-Arg uptake, with a Ki 10-fold
larger than the Km for L-Arg activation of transport (8). The
other status publication literally reports ‘‘.the failure of D-
Arg to inhibit competitively the transport of its stereo-
isomer.’’ at concentrations up to 3 mM (9).
In light of this scarce and contradictory information, we
decided to investigate the effect of D-Arg on L-Arg-acti-
vated currents in whole-cell voltage-clamped ventricular
cardiomyocytes, with the aim to clarify whether the D-enan-
tiomer is a competitive inhibitor of L-Arg transport and todoi: 10.1016/j.bpj.2010.09.025
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carrier proteins work.
Portions of this study have been previously published in
abstract form (10).METHODS
Adult male rats were injected intraperitoneally with Nembutal,
100 mg kg–1, in accordance with Institutional Animal Care and Use
Committee guidelines, and their hearts were removed under complete anes-
thesia. Single ventricular myocytes were enzymatically isolated using pub-
lished methods (11).Steady-state voltage-clamp experiments
Freshly isolated ventricular cardiomyocytes were placed in a superfusion
chamber on the stage of an inverted microscope and superfused at 36 5
1C with a Tyrode solution containing (in mM) 145 NaCl, 5 KCl,
10 dextrose, 2 CaCl2, 1 MgCl2, and 10 Hepes/NaOH, pH 7.40 (23
C).
Myocytes were voltage-clamped in the whole-cell configuration with
low-resistance (1.0–1.5 MU) patch electrodes back-filled with an intracel-
lular salt solution containing (in mM) 110 potassium aspartate, 20 TEACl,
4 MgCl2, 0.7 ATP-Mg
2þ salt, 10 EGTA/Tris, 5 glucose, and 10 Hepes/
KOH, pH 7.30 (23C). Voltage-clamp experiments were performed with
a low-noise Axopatch 200B patch-clamp amplifier using a Digidata 1400
and pCLAMP 10 software for data acquisition and analysis (Molecular
Devices, Sunnyvale, CA).
After establishing a Giga-Ohm seal, the superfusion solution was
switched to a Naþ- and Kþ-free solution containing (in mM) 145 tetrame-
thylammonium chloride (TMACl), 2.3 MgCl2, 0.2 CdCl2, 5.5 dextrose, and
10 Hepes/Tris, pH 7.40 (23C). L-Arg- and D-Arg-containing solutions
were prepared on the day of the experiment by equimolar substitution of
TMA. Extracellular TMA and Cd2þ, as well as intracellular TEA, were
added to block contaminating ionic currents, as previously described to
isolate Na,K-pump current (12). Cells were exposed to these blockers for
5 min before further manipulations.Voltage-clamp protocol
Step changes of 100 ms in VM were produced from a holding potential
of 40 mV to various VM in the range 100 to þ40 mV, in 10-mV incre-
ments at 2 Hz. These VM jumps were applied before and during superfusion
with L-Arg-containing solution, and again after L-Arg removal, to obtain
the respective current-VM relationships. L-Arg currents were defined as
the difference between current levels measured in the absence and presence
of the amino acid.Pre-steady-state voltage-clamp experiments
To measure transient charge movements, protocols were followed as previ-
ously outlined (12). Experiments were performed at 19–21C (to slow the
kinetics of current relaxation) with Naþ- and Kþ-free superfusion solutions
containing (in mM) 145 TMACl, 2.3 MgCl2, 0.2 CdCl2, 5.5 dextrose, and
10 Hepes/Tris, pH 7.4 (20C). The hydrochloride salt of D-arginine was
added to this solution as indicated. The patch electrode solution contained
(in mM) 110 cesium sulfamate, 20 TEACl, 4 MgCl2, 0.7 ATP-Mg
2þ salt,
10 EGTA/Tris, 5 dextrose, and 10 Hepes/CsOH, pH 7.2 (20C).Voltage-clamp protocol
In all experiments, the holding potential was 40 mV. When needed,
voltage steps 100 ms long from 160 to þ100 mV were elicited in20-mV increments at 2 Hz. Each protocol was performed in the presence
and absence of D-Arg so that D-Arg-sensitive difference currents could
be obtained. Corrections for junction potentials were not carried out.Data analysis
Current traces were sampled at 10 kHz and 25 Hz, and low-pass filtered at
3 kHz and 6 Hz for pre-steady-state and steady-state measurements, respec-
tively. Linear cell capacitance was calculated with Clampex using 5-mV
depolarizing pulses, and current analysis was performed with Clampfit.
Clampex and Clampfit routines are included in pClamp 10 (Molecular
Devices). Data are displayed as the mean 5 SE for the indicated number
of experiments. Statistical significance was determined using the Student’s
t-test (P < 0.05). Curve-fitting was performed with nonlinear least-squares
routines included in SigmaPlot v10.0 (Systat Software, Chicago, IL) using
statistical weights proportional to (SE)–2.RESULTS
Effect of D-Arg on L-Arg-activated currents
To study the effect of D-enantiomers on cationic L-amino
acid transport, L-Arg currents were measured in myocytes
voltage-clamped at 40 mV with patch electrodes filled
with a high-Kþ intracellular salt solution and superfused
with a Naþ- and Kþ-free, 145-mM TMA-containing solu-
tion. Under these conditions, increasing concentrations of
extracellular L-Arg (L-Argo) elicited progressively larger
currents, as shown in Fig. 1 A for 1, 5, and 10 mM L-
Argo. The VM dependence of current was studied in the
range 100 to þ40 mV by applying a voltage-clamp
protocol (described in Methods) after L-Arg-activated
currents reached a steady state at 40 mV. Baseline curves
obtained 30 s before L-Arg application and 2–3 min after
withdrawal of the amino acid were averaged and subtracted
from those obtained in the presence of L-Arg. The corre-
sponding difference current (IM)-VM relationships collected
from 12 myocytes are shown in Fig. 1 B for the concentra-
tions of L-Argo used in Fig. 1 A. Current levels increased
with more negative VM at all L-Argo concentrations tested.
This VM dependence was still apparent at L-Arg concentra-
tions as high as 50 mM (not shown), suggesting the exis-
tence of additional electrogenic reaction steps not
involved in L-Arg binding/release (see also Peluffo (1)).
When myocytes were superfused with a 10 mM L-Argo-
containing solution, increasing concentrations of D-Argo
produced a concomitant decrease in current density levels
(Fig. 1 A). Inspection of IM-VM relationships obtained
from 14 cells treated with 0, 10, and 30 mM D-Arg shows
that the inhibitory effect of the D-enantiomer was more
pronounced at hyperpolarizing potentials (Fig. 1 C). As an
example, 10 and 30 mM D-Arg inhibited L-Arg currents
by 48 and 77% at 100 mV, respectively, and by 26 and
53% at 10 mV, respectively. For comparison, application
of 10 mM D-Argo in the absence of L-Argo elicited negli-
gible inward currents at all VMs tested (Fig. 1 C, solid trian-
gles). Altogether, these results indicate that L-Arg currents
are blocked by D-Arg in a VM-dependent manner.Biophysical Journal 99(10) 3224–3233
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FIGURE 1 Effect of D-Arg on extracellular
L-Arg-activated currents in whole-cell voltage-
clamped cardiomyocytes. (A) Inward currents
were elicited by increasing concentrations of
L-Arg at a holding potential of 40 mV in the
absence or presence of increasing concentrations
of D-Arg. (B) IM-VM relationships obtained by
applying voltage jumps to currents measured in
the presence of 1 (C), 5 (B), and 10 (;) mM
L-Argo. Symbols represent average difference
current values calculated for the last 70 ms of the
applied voltage pulses, defined as steady-state
current. (C) IM-VM relationships for 10 mM
L-Arg-activated currents obtained in the presence
of 0 (B), 10 (C), and 30 (6) mM D-Argo. A
curve obtained with 10 mM D-Argo and no added
L-Arg is also included (;) to show that the
D-enantiomer is poorly (if at all) transported.
Symbols represent the mean 5 SE of three to
five experiments for each condition. Curves in B
and C were calculated with Eq. 1 and the best-fit
parameters obtained by simultaneously fitting this
equation to the entire data set (see text for details).
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To determinewhether D-Arg inhibitionwas competitivewith
L-Arg activation of current, the experiments described above
(see Fig. 1) were repeated with L-Arg concentrations in the
range 1–50 mM. Whenever possible, the effects of 10 and
30 mM D-Arg, as well as control-current levels, were tested
in the same myocyte. The concentration dependence of
D-Arg effects on L-Arg-activated current at selected VM is
summarized in Fig. 2. In a preliminary analysis of these
results, data at each D-Arg concentration and VM were fit
with single decreasing hyperbolic functions. The L-Arg
concentration required for half-maximal activation of current
(K0.5) andmaximal current density levels (Imax) are presented
as functions of VM and D-Arg concentration in Fig. 3. L-Arg
K0.5 values increased both with depolarization and with the
concentration of D-Arg (Fig. 3 A). For example, K0.5 at
zero VMwas found to have values of 10.95 0.9, 20.65 2.6,
and 41.75 2.7mM at 0, 10, and 30mMD-Arg, respectively.
Imax increased (in absolute value) with hyperpolarization,
showing no signs of saturation at up to 100 mV (Fig. 3 B).
It is important to note that Imax values were not statistically
significantly different at any of the D-Arg concentrations
tested. This behavior of K0.5 and Imax as a function of
D-Arg is, by definition, that of a competitive inhibitor. There-
fore, considering the results in Fig. 1 C, D-Arg appears to beIM ¼ I
0
maxexpð 
1 þ
h
K0
0:5
½LArg exp

lLArg U
ih
Biophysical Journal 99(10) 3224–3233a VM-dependent competitive blocker of L-Arg transport. In
addition, since Imax is defined for L-Arg concentrations
approaching infinity, its VM dependence (Fig. 3 B) indicates
that steps other than L-Arg binding move a substantial
amount of charge across the membrane electric field.
Pseudo-three-state reaction scheme
The effect of D-Arg on L-Arg transport was analyzed
according to the reaction scheme (Scheme 1)
SCHEME 1
where To is the outward-facing conformation of the cationic
amino acid transporter, ToD is the D-Arg-bound complex,
and ToL is the L-Arg-bound complex. One of the hemiloops
represents extracellular L-Arg binding; the other lumps
together L-Arg translocation and release, as well as reorien-
tation of the protein to the outward-facing conformation.
Solution of this Scheme in terms of electrogenic L-Arg
transport yielded the expressionlturnover UÞ
1 þ ½DArg
K0
i
exp
 lDArg U
i; (1)
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FIGURE 2 L-Argo-concentrationdependence of current atVM¼100mV
(A),40mV(B), andþ20mV(C) for 0 (C), 10 (B), and 30mMD-Arg (;).
Ordinate scaling in B and C was kept proportional to that in A to highlight
the dramatic decrease in current levels with depolarization at all L-Arg
concentrations tested. Curves were generated with Eq. 1 and the best-fit
parameters obtained by fitting this equation to the entire dataset.
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FIGURE 3 Effect of D-Arg and VM on kinetic parameters of L-Arg trans-
port. (A) L-Arg K0.5-VM relationships in the presence of 0 (C), 10 (B), and
30 mM D-Arg (;). Symbols were obtained by fitting single hyperbolic
functions to the data at each D-Arg concentration and VM. Curves were
calculated at each D-Arg using the best-fit parameters from Eq. 1 on the
expression for K0.5,
K0:5 ¼ K00:5 exp

lLArg U


1 þ ½D Arg
K0i
exp
lDArg U

;
that is included in the denominator of Eq. 1. (B) Imax-VM relationships for
0 (C), 10 (B), and 30 mM D-Arg (7). Symbols represent Imax values
obtained by fitting hyperbolic functions to the data at each D-Arg concen-
tration and VM. The curve, which represents the numerator of Eq. 1, was
calculated using the best-fit values of I0max and lturnover.
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defined at VM ¼ 0; l values are dielectric coefficients that
represent the portion of the membrane electric field dissi-
pated by the given reaction; K0.5 is the concentration of L-
Arg that produces half-maximal activation of transport; Ki
is the concentration of D-Arg that produces half-maximal
inhibition of transport; and U is the dimensionless trans-
membrane voltage expressed as zFVM/RT. Consistent with
results presented in Figs. 1–3, Eq. 1 is the expression for
L-Arg current with a VM-dependent turnover rate in the
presence of a VM-dependent competitive inhibitor.
Equation 1 was simultaneously fit in three variables to the
entire dataset, yielding the six best-fit parameter values
shown in Table 1. Notice that lturnover > lL-Arg ¼ lD-Arg,
and that K00.5 y K
0
i. To visualize whether Scheme 1
accounts for all experimental features of these currents,
Eq. 1 was solved with these parameter values and plotted
in Figs. 1, B and C, 2, and 3 (solid lines). Scheme 1 properly
describes the VM dependence of L-Arg currents at different
L-Arg (Fig. 1 B) and D-Arg concentrations (Fig. 1 C). The
reaction scheme also accounts well for the L-Arg and D-Arg
concentration dependence of current at any given VM
(Fig. 2). Accordingly, the values of L-Arg K0.5 and Imax,
calculated by individually fitting hyperbolic functions ateach D-Arg concentration and VM, are reasonably well
described by the pseudo-three-state model (Fig. 3). Taken
together, these results demonstrate that D-Arg is a VM-
dependent competitive inhibitor of L-Arg transport in
cardiac myocytes. Furthermore, D-Arg and L-Arg dissipateBiophysical Journal 99(10) 3224–3233
TABLE 1 Parameter values describing the pseudo-three-state
model
I0max (pA pF
–1) –1.065 0.06
lturnover 0.415 0.02
K00.5 (mM) 10.15 0.8
lL-Arg 0.145 0.05
K0i (mM) 8.35 0.5
lD-Arg 0.135 0.05
The pseudo-three-state model is depicted in Scheme 1. Parameter values
were obtained by simultaneously fitting the entire dataset with Eq. 1.
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FIGURE 4 D-Arg-dependent transient charge movements. (A) Superim-
posed current traces elicited by voltage pulses from 40 mV to voltages in
the range 160 to þ100 mV were measured in a whole-cell voltage-
clamped cardiac myocyte superfused with D-Arg-free (left) or 10 mM
D-Arg-containing solution (right). (B) Current traces from A in the absence
and presence of D-Arg are displayed superimposed at two selected VM to
show the area contained within both sets of curves. (C) Superimposed
D-Arg-sensitive difference currents at selected VM. The solid curves
through the decaying phase of current traces are best-fit exponential func-
tions. (D) Difference currents determined by subtracting membrane
currents recorded before D-Arg application from those obtained 3 min after
removal of the amino acid. Superimposed currents are shown for voltage-
clamp steps to 120, 60, 0, and þ60 mV.D-Arg-dependent charge movements
Based on the findings above, it is anticipated that to block
L-Arg transport in a VM-dependent manner, D-Arg will
move its net positive charge within the membrane electric
field, thus producing D-Arg-dependent charge movements.
To test this prediction, ventricular cardiomyocytes were
whole-cell voltage-clamped at a holding potential of
40 mV with wide-tipped patch electrodes backfilled
with a 115 mM Csþ-containing solution and superfused
with a 145 mM TMA-containing, Naþ- and Kþ-free
external solution at 20C. Voltage steps (see Methods)
were applied before, during, and after exposure to 10 mM
D-Arg, yielding current traces such as those shown
superimposed in Fig. 4 A, before (left) and after (right)
2 min in the presence of the amino acid. The concentration
of D-Arg was selected to be close to the K0i value deter-
mined above because nonsaturation of the binding site
with ligand is a prerequisite for the detection of charge
movements. A detail of traces obtained with voltage steps
to 100 and þ60 mV in the absence and presence of
D-Arg is shown in Fig. 4 B. The surface enclosed by
both curves represents the amount of charge that was
moved at each VM. Upon subtraction, D-Arg-sensitive
difference currents were obtained. Fig. 4 C shows selected
transient currents elicited by voltage pulses from 40 mV
to 120, 60, 0, and þ60 mV (‘‘on’’ currents), and back to
40 mV from 60, 0, and þ60 mV (‘‘off’’ currents). The
off-current trace corresponding to 120 mV was omitted
because of current contamination at VM <100 mV. The
quantity of charge moved at the onset of voltage pulses
was calculated to be 4.5, 1.2, þ1.5, and þ3.1 fC
pF1, respectively. Likewise, current relaxation followed
single-exponential kinetics (see superimposed fitting for
‘‘on’’ currents), with apparent rate-constant (ktot) values
of 1100, 828, 941, and 1055 s1, respectively. In all cases,
currents decayed at rates that were at least fourfold slower
than charging of linear membrane capacitance (typical
clamp time constants were 210–250 ms). Voltage-clamp
stability was tested by comparing current traces obtained
before D-Arg application and 3 min after washout of theBiophysical Journal 99(10) 3224–3233amino acid (total elapsed time, 5.5 min). Superimposed
difference currents yielded residual charge amounts that
were 5–9 % of the D-Arg-sensitive charge in Fig. 4 C at
equivalent voltage pulses (Fig. 4 D). Therefore, changes
in clamp stability were negligible over the duration of these
experiments and, thus, transient charge movements are
D-Isomer Effects on L-Arginine Transport 3229genuinely associated with D-Arg binding/unbinding reac-
tions.
Experiments were also performed with 5 mM D-Arg to
study the concentration dependence of charge movements
(see Fig. S1 in the Supporting Material). The salient featureCharge (fC pF-1)
001061-
-6
6
VM  (mV)
-160 -80 0 80
400
800
1200
1600ktot  (s
-1)
VM  (mV)
C
A
-160 -80 0 80
N
or
m
al
iz
ed
 c
ha
rg
e
0.0
0.5
1.0
VM  (mV)
B
FIGURE 5 VM dependence and kinetics of D-Arg-dependent charge
movement. (A) VM dependence. Ten millimolar D-Arg-sensitive charge
calculated during voltage pulses to the indicated VM (DQon) and afterof these transient currents is that depolarizing VM greatly
increased current relaxation rates. In the example shown,
ktot values went from 490 to 880 s
1 by changing VM
from 20 to þ60 mV.VM dependence of steady-state charge
distribution
The quantity of charge moved (DQ), calculated as the time
integral of transient currents produced by voltage pulses
from 160 to þ100 mV (‘‘on’’ charge) and after returning
to the holding potential (‘‘off’’ charge), was characterized
as a function of VM. Fig. 5 A shows DQ-VM relationships
for 10 mM D-Arg-sensitive ‘‘on’’ and ‘‘off’’ charge. Values
of DQ were found to saturate at large negative and positive
potentials, which suggests that these charge movements
involve redistribution of a finite number of charged particles
in the membrane. The nonlinearity of the steady-state
charge distribution enabled analysis with the Boltzmann
function (Fig. 5 A, solid lines):
DQ ¼ Qmin þ Qtot =

1 þ expzqFV1 = 2  VMRT	
;
(2)
where Qtot ¼ Qmax  Qmin is the total quantity of mobile
charge, zq represents the apparent valence obtained from
steady-state charge distribution measurements, and V1/2 is
the midpoint potential, i.e., the VM at which the concentra-
tions of D-Arg-bound and -free transporter are equal.
Best-fit parameters for ‘‘on’’ and ‘‘off’’ charge are reported
in the figure legend (Fig. 5). The absolute values ofQtot were
not statistically significantly different for Qon and Qoff, indi-
cating that the same amount of charge was reversibly movedreturning to the holding potential (DQoff) are represented by solid circles
and open triangles, respectively (n ¼ 5). Curves through the data represent
fitting of Eq. 2 with the best-fit parameter values:
DQon (10 mM) DQoff (10 mM) DQon (5 mM)
Qtot (fC pF
1) 9.65 1.3 9.35 1.5 10.25 0.8
V1/2 (mV) 29.85 3.7 20.15 3.8 79.15 4.8
zq 0.745 0.19 0.765 0.18 0.705 0.13
Qmin (fC pF
1) 4.35 0.6 3.85 0.9 7.05 1.5
(B) DQon-VM curves comparing data at 5 (B, n ¼ 3) and 10 mM D-Arg
(C). Data were normalized as follows, using the parameter values listed
above:
ðDQ QminÞ=Qtot ¼

1 þ exp½zqFðV1 = 2  VMÞ=RT

1
(C) Kinetics. The decaying portions of D-Arg-sensitive charge movements
were fit with exponential functions (see Fig. 4 C) and the resulting rate
constants (ktot) were plotted against VM for 5 (B) and 10 mM D-Arg
(C). Data points were then simultaneously fit with Eq. 3 to yield the solid
curves and the best-fit parameter values:
kf
0 (s1 mM–1) 76.35 6.2
d 0.195 0.06
zk 0.505 0.15
kr
0 (s1) 214.65 51.1
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3230 Zhou and Peluffoin each direction. The midpoint potential, V1/2, was found to
be slightly more negative for ‘‘on ‘‘than for ‘‘off’’ charge.
Finally, the apparent valence of the mobile charges was
similar and slightly <1 in both cases.
Charge-VM relationships obtained with 5 mM D-Arg
were also analyzed with Eq. 2, and best-fit parameters for
Qon are reported in Fig. 5. The value of Qtot was not statis-
tically significantly different from that obtained with 10 mM
D-Arg. In a similar way, zq remained unchanged at both
D-Arg concentrations. On the other hand, the midpoint
potential shifted ~50 mV when the concentration of
D-Arg was doubled. This shift in V1/2 is shown in Fig. 5 B
for normalized DQ-VM relationships. Altogether, this
behavior is consistent with D-Arg binding in an ion well.The VM-dependent kinetics of current relaxation
To study the effect of voltage on the kinetics of current
decay, ktot values were obtained at all VM tested by fitting
exponential functions to D-Arg-sensitive current traces.
The results, plotted as ktot-VM relationships for 5 and
10 mM D-Arg-dependent charge movements (Fig. 5 C),
show a U-shaped dependence on VM. Data analysis was
performed by simultaneous fitting in two variables of
Eq. 3, which considers ktot as the sum of VM-dependent
forward and reverse rate constants that describe binding
reactions:
ktotðVM; ½D ArgÞ ¼ k0f ½D Argexpf  f zkF VM=RTg
þ k0r expfð1 fÞ zkF VM=RTg;
(3)
where kf
0 and kr
0 are the second-order forward and first-
order reverse rate constants at zero VM; f is a symmetry
factor (0 % f % 1) that accounts for the effect of VM on
the forward and reverse reaction steps, and zk represents
the apparent valence of the mobile charges as determined
by kinetic measurements. Best-fit parameters, listed in the
figure legend, show three distinct features. First, the value
of kf
0 (76,300 5 6160 s–1 M–1 at VM ¼ 0) corresponds to
a process far slower than diffusion. Second, a f¼ 0.19 indi-
cates that the VM dependence lies largely on the reverse
reaction (D-Arg release). Finally, the apparent valence of
the mobile charges, although lower on average, was not
significantly different from zq, the value obtained from
steady-state charge distribution.
In conclusion, these results confirm the prediction that
as a VM-dependent blocker of L-Arg transport, D-Arg
binding reactions move charge within the membrane electric
field.DISCUSSION
The D-enantiomer of arginine was found to be a VM-depen-
dent competitive inhibitor of low-affinity cationic L-aminoBiophysical Journal 99(10) 3224–3233acid transport in cardiac myocytes and, as such, was used
as a tool to gain insights into how these carrier proteins
work. The result lL-Arg ¼ lD-Arg indicates that both stereo-
isomers bind to sites located at the same electrical distance
within the transporter. Together with the comparable values
found for K00.5 and K
0
i, and the fact that D-Arg is not trans-
ported, this result suggests that D- and L-Arg compete
equally efficiently for the same binding site and, thus, enan-
tiomer recognition might occur downstream at conforma-
tional transitions associated with amino acid translocation.
Furthermore, these conformational transitions are probably
what rate-limit the kinetics of D-Arg-dependent charge
movements (Fig. 5 C). The ability of the binding site to
accommodate both stereoisomers is reminiscent of the
induced-fit model proposed for enzyme kinetics (13), which
postulates that enzymes are rather flexible structures with
active sites continually being reshaped by their interactions
with the substrate.
Extracellular binding reactions dissipate ~15% of the
membrane electric field, i.e., are weakly VM-dependent, so
that the main electrogenic step must involve either amino
acid translocation, or release to the opposite side, or reorien-
tation of the unliganded carrier to the extracellular side.
Such a prediction correlates well with the observed VM
dependence of Imax (lturnover ¼ 0.41), a parameter defined
at [L-Arg] / N and, thus, independent of extracellular
L-Arg binding reactions. Moreover, the shape of the Imax-
VM relationship is consistent with a single charge-transloca-
tion event that is also the rate-limiting step in the reaction
cycle (14). Considering a four-state alternating model for
L-Arg transport (Scheme 2), reasonable candidates for this
charge-moving slow step include translocation of the loaded
or unliganded transporter.
SCHEME 2
In this model, T represents a transporter molecule that
can exist in extracellular- (To) and intracellular-facing con-
formations (Ti). ToL and TiL are the corresponding confor-
mations for the L-Arg-bound complex. Rate constants k1,
k2, k3, and k4 describe the L-Arg (Lo) inward transport
process. Rate constants k2, k–1, and k4 describe outward
translocation of the L-Arg-bound complex, Lo release, and
the inward reorientation of the unliganded transporter,
D-Isomer Effects on L-Arginine Transport 3231respectively, under zero-trans conditions ([Li] ¼ 0). The
steady-state expression for current generated by L-Arg
import can be derived using the King and Altman algorithm
(15) asIo/iM ¼ zF½TT
k1k2k3k4½Lo
½k2ðk3 þ k4Þ þ k4ðk3 þ k2Þk1½Lo þ ½k1ðk3 þ k2Þ þ k2k3ðk4 þ k4Þ; (4)where [T]T is the total concentration of cationic amino acid
transporters in the membrane. Accordingly, the expression
for Imax is
Io/imax ¼
zF½TT
1
k4
þ 1
k3
þ 1
k2
þ k2
k2k3
: (5)
Equation 5 can be expressed as an explicit function of VM:Io/imax ¼
zF½TT
expðhUÞ
k04
þ expðgUÞ
k03
þ expðbU=2Þ
k02
þ k
0
2exp½ðb þ gÞU
k02k
0
3
; (6)
    163     166              405           411 
CAT-1  A E N P  D  I  F A V  I...........................L F  D  L K D L V  D   L 
CAT-2A A E Y P  D  F F A V C...........................L F  D  L K A L V  D  M 
CAT-2B A E Y P  D  F F A V C...........................L F  D  L K A L V  D  M 
CAT-3  A E Y P  D  F F A L A...........................L F  K  L T  D L V D   L 
FIGURE 6 Amino acid sequence comparison of human CAT-1, -2A, -2B,
and -3. Sequences of putative transmembrane segments (TMs) 4, 9, and 10
(according to Habermeier et al. (16)) were aligned using BLAST. Numbers
above the sequences refer to the positions of four negatively-charged resi-
dues within or near the TMs. Gray boxes indicate highly conserved amino
acid residues located in extracellular-facing portions of TMs 4 and 10. The
white box indicates a residue that is not conserved in CAT-3. Amino acid
residue 163 is not located within the membrane electric field with this
arrangement of TMs (16).where kj
0 indicates rate constants defined at zero VM, z is the
valence of the charged particles crossing the membrane, and
b, g, and h are dielectric coefficients for the partial reactions
described by the respective rate constants. The explicit
expression for k4 as a function of VM is given here as an
example: k4 ¼ k40 exp(hU).
Simulations with Eq. 6 that assign the VM-dependent rate-
limiting step to either translocation of the unloaded carrier
(k4, h > 0, b ¼ 0) or the L-Arg-bound complex (k2 and
k2, b > 0, h ¼ 0) yield indistinguishable Imax-VM relation-
ships (Fig. S2). However, the phenomenon of trans-stimula-
tion (8), a distinctive feature displayed by this family of
transporters in which unlabeled trans-substrate increases
severalfold the rate of cationic amino acid uptake, indicates
that the reaction ToL4 TiL is indeed fast (2,4,7). Therefore,
translocation of the unliganded transporter Ti / To
(described by k4) appears to be the slow VM-dependent reac-
tion. In this case, the outward movement of a negative
charge must accompany reorientation of the unoccupied
transporter to be consistent with the observed current
polarity and VM dependence of Imax. This scenario suggests
that a negatively charged residue located at or near the
cationic amino acid binding site interacts with the distal
positive charge of these compounds upon binding, thus
leading to the electroneutral translocation of the L-Arg-
bound complex (b ¼ 0) and the electrogenic outward reor-
ientation of the unliganded transporter (h > 0).
Based on the proposed topology of the human CAT-2A
isoform (16), which displays a >90% homology with itsmurine counterparts (17), we identified three negatively
charged residues located in the extracellular-facing portion
of transmembrane segments (TMs) 4, 9, and 10. Two of
these residues, Asp166 (TM4) and Asp411 (TM10) areconserved in all four CAT isoforms (Fig. 6). Asp405
(TM9), on the other hand, is replaced by a positively
charged lysine in CAT-3 and, thus, this residue is unlikely
to participate in stabilizing cationic amino acid binding
unless the transport mechanism is substantially different in
this isoform. Therefore, Asp166 and Asp411 are potential
candidates to supply the negative charge at the cationic
amino acid binding pocket. Nonetheless, small shifts in
TM assignments may bring into consideration additionalamino acids, such as the highly conserved Glu163 (Fig. 6)
located outside the membrane electric field in this model
(16).
The dielectric coefficients in Eq. 6 are bound by the
constraint
b þ g þ h ¼ n a; (7)
where n is the number of elementary charges moved per
cycle from one side to the opposite side of the membrane
and a is the dielectric coefficient for extracellular Arg
binding (k1) and release (k1). To estimate h, we used the
notion that the electrogenicity of Imax must reflect that of
the VM-dependent rate-limiting step and, thus, this dielectric
coefficient (which affects k4) was assigned the valueBiophysical Journal 99(10) 3224–3233
3232 Zhou and Peluffo0.41 (lturnover). As discussed above, this implies that translo-
cation of the L-Arg-bound complex is electroneutral, i.e.,
b ¼ 0. In addition, the value found for lL-Arg (0.14) was
chosen as a reasonable approximation for a, even though
the expression for K00.5 in Eq. 1 is an algebraic combination
of all rate constants that describe Scheme 1. In terms of the
actual value of n, it is important to notice that these organic
compounds do not have fixed charges. Instead, the net
charge of cationic amino acids is set by the pH of the
bathing solution. Multiple equilibria analysis of L-Arg inter-
mediates with different degrees of dissociation indicates that
the form ArgH2
þ accounts for practically 98% of total Arg
at pH 7.4, the remaining 2% corresponding to the uncharged
ArgH (see Supporting Material). Thus, using n¼ 0.98, Eq. 7
yields g ¼ 0.43. This result predicts that L-Arg will sense
almost half of the membrane electric field during intracel-
lular release. However, since this reaction is anticipated to
be fast (probably diffusion-limited), its electrogenicity will
not be easily detected.
The value of k4, which likely describes the charge-moving
rate-limiting step, will become larger than k2 at sufficiently
negative VM values (Eq. 6). In such a case, it is anticipated
that the IM-VM relationship will display a plateau associated
with the electroneutral ToL4 TiL transition. However, it is
not known whether these voltages fall within the experimen-
tally achievable range. In the case of the high-affinity CAT-1
heterologously expressed in Xenopus oocytes, currents do
not saturate at VM as negative as 180 mV (18).
Transient charge movements
Transient currents were measured in the presence of extra-
cellular D-Arg, indicating that this compound binds to the
carrier at extracellular-facing sites located within the
membrane electric field. This finding was consistent with,
and provided further support for, steady-state measurements
of D-Arg as a VM-dependent competitive blocker of L-Arg
transport. Boltzmann analysis of the quantity of mobile
charge as a function of VM showed that a total (Qtot) of
~10 fC pF1 were moved by D-Arg carrying roughly one
net positive charge (zq ¼ 0.75 5 0.20). Knowing that
Qtot ¼ zF[T]T, a value of ~600 mm2 was estimated for
the density of low-affinity cationic amino acid transporters
on the rat cardiomyocyte plasma membrane.
The shift in midpoint potential produced by doubling
the concentration of extracellular D-Arg was consistent
with binding of this amino acid in an ion well. In fact, the
ion well depth (d) can be calculated from this shift in V1/2
as follows (for a derivation of Eq. 8, see Peluffo (19)):
DV1= 2 ¼ RT
d F
ln
½D Arg2
½D Arg1
: (8)
Solution of Eq. 8 at 293.15 K yields d ¼ 0.36, a value indic-
ative of the small portion of the membrane electric field
sensed by mobile charges during binding reactions.Biophysical Journal 99(10) 3224–3233The common assumption of an apparent molecularity of
n ¼ 1 for the charge-moving process, knowing that the
valence of the charged species has an upper-limit value of
n ¼ 1 with our experimental conditions (see above), leads
to an inconsistency between the value of d and the measured
apparent valence, defined as zq ¼ nnd (20). Indeed, the
actual stoichiometry for these transporters has not been
determined. The assumption that one L-amino acid mole-
cule is bound and transported per cycle is largely based on
the hyperbolic dependence of uptake (4,7) and current ((1)
and Fig. 2 of this work) curves with the concentration of
substrate. However, a similar behavior is expected from
binding of two (or more) substrate molecules to identical,
noninteracting sites in the carrier. Therefore, a simple way
to reconcile the values of d and zq is to assume that n ¼ 2.
In the case of L-Arg, transport of two molecules of substrate
per cycle may also help to explain in part the high capacity
of this low-affinity transporter.
Kinetic analysis showed that charge movements are
rate-limited by a conformational change, which follows
fast D-Arg binding reactions and is likely associated with
TM rearrangements that prepare L-Arg translocation. The
apparent rate constant for current relaxation was found to
be a mild U-shaped function of VM, with the VM dependence
residing largely in the reverse (release) reaction. This
asymmetry, together with the small portion of the membrane
electric field dissipated by D- and L-Arg binding reactions
and the value found for d, suggests that the transporter
might have a shallow, water-filled extracellular binding
pocket.
Although pure binding reactions were not measured, an
apparent equilibrium constant for the dissociation of
D-Arg, Kd ¼ 2.8 5 0.7 mM, was estimated as kr0/kf0.
This Kd value is not expected to match that of K
0
i because
of the different temperatures used for transient charge move-
ment and steady-state current measurements, and the fact
that K0i is also affected by the rate of reorientation of the
unoccupied transporter.
In summary, the combination of pre-steady-state and
steady-state measurements using the D-enantiomer of argi-
nine yielded new quantitative information on the VM-depen-
dent mechanism of L-Arg transport, as well as some testable
predictions on the structure-function of a low-affinity
cationic amino acid transporter.SUPPORTING MATERIAL
Transient currents obtained with 5 mM D-Arg (Fig. S1); analysis of the
contribution of arginine intermediates with different degrees of dissociation
to total arginine concentration at pH 7.40; and simulations of Imax-VM rela-
tionships with Eq. 6 (Fig. S2) are available at http://www.biophysj.org/
biophysj/supplemental/S0006-3495(10)01172-0.
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